Bionano Genomics, Inc. Long-Term Debt, Maturity, Year Four
Bionano Genomics, Inc. (BNGO) had Long-Term Debt, Maturity, Year Four of $1.89 million as of 2020-12-31, per its 10-K filed 2021-03-23.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour · last filed 2021-03-23
- 2020-12-31: Long-Term Debt, Maturity, Year Four $1.89M.
- 2019-12-31: Long-Term Debt, Maturity, Year Four $7.93M.
| Period end | Long-Term Debt, Maturity, Year Four |
|---|---|
| 2020-12-31 | $1.89M 10-K · filed 2021-03-23 |
| 2019-12-31 | $7.93M 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |